Abstract
We read the study of Yilmaz et al. [ [1] Yilmaz Y. Ozturk O. Alahdab Y.O. et al. Serum osteopontin levels as a predictor of portal inflammation in patients with nonalcoholic fatty liver disease. Digestive and Liver Disease. 2013; 45: 58-62 Abstract Full Text Full Text PDF Scopus (18) Google Scholar ], with great interest, that investigated whether serum osteopontin (OPN) concentrations are associated with liver histology in patients with nonalcoholic fatty liver disease (NAFLD). In their univariate analysis, they found that serum OPN levels were significantly associated with portal inflammation, which suggests that OPN represents a novel and powerful biomarker for NAFLD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
